3 completed, 3 terminated. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Terminated 3 |
| Phase 2 | 2 | Completed 2 |
Follow Farydak: new trials by email Literature Review of Farydak trials Research Report on Farydak
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone - Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 | Terminated | Abdullah Khan | 1 | 2021-09-27 | 2024-06-06 |
| Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) Panobinostat 15 MG, Focused Ultrasound with neuro-navigator-controlled sonication - Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas | Phase 1 | Terminated | Columbia University | 5 | 2021-07-28 | 2025-06-08 |
| Phase I Study of Marizomib + Panobinostat for Children With DIPG Marizomib, Panobinostat - Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma | Phase 1 | Terminated | Dana-Farber Cancer Institute | 4 | 2020-08-10 | 2024-02-15 |
| Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy Panobinostat, Pegylated Interferon-alpha2a - HIV Infection | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 17 | 2016-05-01 | 2024-02-28 |
| Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma Carfilzomib, Panobinostat - Non-Secretory Plasma Cell Myeloma, Plasmacytosis | Phase 1 | Completed | M.D. Anderson Cancer Center | 63 | 2011-07-28 | 2023-09-29 |
| LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma LBH589, bevacizumab - Malignant Glioma | Phase 1 / Phase 2 | Completed | Patrick Y. Wen, MD | 51 | 2009-03-01 | 2017-03-14 |
Diffuse Intrinsic Pontine Glioma (2) · Multiple Myeloma (2) · Glioma (1) · HIV Infections (1) · Neoplasms (1) · Recurrence (1)
Abdullah Khan (1) · Columbia University (1) · Dana-Farber Cancer Institute (1) · M.D. Anderson Cancer Center (1) · Massachusetts General Hospital (1) · Patrick Y. Wen, MD (1)
United States (6)
Abdullah M Khan, MBBS, MSc (1) · Cheng-Chia Wu, MD, PhD (1) · Daniel R Kuritzkes, MD (1) · Katherine Warren, MD (1) · Mathias Lichterfeld, MD, PhD (1) · Patrick Y. Wen, MD (1) · Rajesh T Gandhi, MD (1) · Robert Orlowski (1)
P30CA016672 (1)